CCP Patient Assessment and Monitoring Questions and Answers

Question 1

An 85-year-old resident with heart failure and hypertension is taking furosemide, lisinopril, and metoprolol. A routine lab draw shows a potassium level of 2.9 mEq/L (Reference range: 3.5-5.2 mEq/L). Which physical sign or symptom is MOST important for the consultant pharmacist to recommend assessing for, given this lab value?

Accepted Answer

Muscle weakness and cramping

Answer

A potassium level of 2.9 mEq/L indicates moderate hypokalemia, which is a known risk with loop diuretics like furosemide. A primary clinical manifestation of hypokalemia is muscle weakness, cramping, and fatigue. While a dry cough is associated with lisinopril, bradycardia with metoprolol, and ankle edema with worsening heart failure, the acute electrolyte abnormality most directly correlates with neuromuscular symptoms.

Question 2

A consultant pharmacist is reviewing a resident with advanced dementia who is non-verbal and frequently exhibits restlessness and grimacing. The nursing staff is unsure if the resident is in pain. Which assessment tool is most appropriate to use to monitor this resident's pain?

Accepted Answer

Pain Assessment in Advanced Dementia (PAINAD) Scale

Answer

The Pain Assessment in Advanced Dementia (PAINAD) Scale is specifically designed to assess pain in individuals with cognitive impairment who cannot reliably communicate their needs. It uses observation of breathing, vocalization, facial expression, body language, and consolability. The NRS, FACES scale, and BPI all require the patient to self-report their pain level, which is not possible for this resident.

Question 3

A consultant pharmacist is asked to assess an 85-year-old resident who was recently started on haloperidol for behavioral disturbances. During the assessment, the pharmacist observes the resident exhibiting involuntary, repetitive puckering of the lips and chewing motions. Which of the following should the pharmacist recommend be performed?

Accepted Answer

An Abnormal Involuntary Movement Scale (AIMS) assessment

Answer

The observed symptoms—involuntary, repetitive movements of the mouth—are classic signs of tardive dyskinesia (TD), a potential side effect of antipsychotic medications like haloperidol. The Abnormal Involuntary Movement Scale (AIMS) is the standard tool used to screen for and assess the severity of TD. While the other assessments are relevant for geriatric patients on antipsychotics, the AIMS directly addresses the specific movements described.

Question 4

When initiating therapy with apixaban in a 78-year-old resident of a long-term care facility, which of the following is the MOST critical baseline and periodic monitoring parameter to guide dosing and ensure safety?

Accepted Answer

Renal function (e.g., eGFR/CrCl)

Answer

The dosing and safe use of direct oral anticoagulants (DOACs) like apixaban are highly dependent on renal function, as the drug is partially cleared by the kidneys. Guidelines recommend assessing renal function at baseline and at least annually (or more frequently in patients with renal impairment or the elderly) to ensure appropriate dosing and minimize bleeding risk. INR is used for warfarin, and aPTT is primarily used for heparin.

Question 5

A consultant pharmacist reviews the chart of a 90-year-old resident who has lost 8% of their body weight in the last 30 days. The resident was started on sertraline 6 weeks ago for depression. Laboratory data shows a serum albumin of 2.9 g/dL (Reference: 3.5-5.0 g/dL). Which medication-related problem is the MOST likely contributor to the resident's status?

Accepted Answer

Adverse drug reaction

Answer

Changes in appetite leading to weight loss are known adverse effects of SSRIs like sertraline, particularly in the elderly. The timeline of the weight loss starting after the initiation of the drug, coupled with the low serum albumin (a marker of poor nutritional status), strongly suggests an adverse drug reaction is the cause. There is no information to suggest the drug is inappropriate, subtherapeutic, or not being administered.

(CCP) Certified Consultant Pharmacist Practice Test

(CCP) Certified Consultant Pharmacist Practice Test

CCP Patient Assessment and Monitoring Questions and Answers